Sign Up Today and Learn More About Aktana Stock

Invest in or calculate the value of your shares in Aktana or other pre-IPO companies through EquityZen's platform.

Get Started

Aktana Stock

Life sciences data-fueled insights

About Aktana Stock

Founded

2011

Headquarters

San Francisco, CA, US

Notable Investor

CIBC Innovation Banking

Total Funding

69.2M

Aktana helps life science companies get the most out of artificial intelligence (AI) for commercializing their products. The company’s proprietary platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments, and drive channel productivity and results. The company’s focus on the life sciences market allows Aktana to understand and incorporate unique market dynamics more deeply than the major AI players. Headquartered in San Francisco, Aktana also has offices in New York, Philadelphia, London, Barcelona, Tokyo, Osaka, and Shanghai.

Investors in Aktana

Discover investors in Aktana stock and explore their portfolio companies

Aktana Management

Leadership team at Aktana

Chief Executive Officer

David Ehrlich

Chief Customer Officer

James Anderson

Locked Features

Join now and verify your accreditation status to gain access to:

  • Aktana current valuation
  • Aktana stock price
  • Available deals in Aktana and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Aktana stock?

Accredited investors can buy pre-IPO stock in companies like Aktana through EquityZen funds. These investments are made available by existing Aktana shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Aktana stock?

Shareholders can sell their Aktana stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."